-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Our Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
IQVIA APAC Insight
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
Career Opportunities
Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search Jobs
WHITE PAPER
National Immunization Programme (NIP) Evolution in Southeast Asia
Jul 24, 2023
Vaccine-preventable diseases and emerging threats, like the COVID-19 pandemic, have highlighted the need for vaccination but also its challenges. National Immunization Programme (NIP) is a governmental schedule that aims to provide selected vaccinations free of cost to the country’s population.
Southeast Asia is a diverse region where healthcare systems continually adapt to new challenges and opportunities presented by their unique demographics, geographies, cultures, and political environments. Therefore, vaccine’s inclusion in National Immunization Programmes across SEA countries requires a strategic and pragmatic approach.
This white paper aims to provide insights into the current state of NIP in SEA, and also identify gaps and key success factors to effectively tackle the challenges for vaccine introduction in NIP to enhance SEA immunization programmes.
For more information, contact us.
Authors
Clemence Lewden
Associate Consultant, Consulting, SEA & APAC RHQ, IQVIA
Jisu Kim
Manager, Consulting, SEA & APAC RHQ, IQVIA
Kean Mun Lau
Manager, Consulting, SEA & APAC RHQ, IQVIA
Deveraj Subramaniam
Associate Principal and Malaysia Consulting Lead, SEA & APAC RHQ, IQVIA